Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Shwachman–Diamond syndrome and solid tumors: 3 new patients from the French severe chronic neutropenia registry and literature review
  • +9
  • Fares BOU MITRI,
  • Blandine BEAUPAIN,
  • Jean-Francois FLEJOU,
  • Matthieu PATIENT,
  • Ilona OKHREMCHUCK,
  • Didier BLAISE,
  • Faézeh IZADIFAR-LEGRAND,
  • Jean-Alain MARTIGNOLES,
  • Francois DELHOMMEAU,
  • Christine Bellanné-Chantelot,
  • Jean-Francois EMILE,
  • Jean Donadieu
Fares BOU MITRI
Armand-Trousseau Childrens Hospital

Corresponding Author:[email protected]

Author Profile
Blandine BEAUPAIN
Armand-Trousseau Childrens Hospital
Author Profile
Jean-Francois FLEJOU
Hôpital Saint-Antoine
Author Profile
Matthieu PATIENT
HIA Sainte Anne
Author Profile
Ilona OKHREMCHUCK
HIA Sainte Anne
Author Profile
Didier BLAISE
Paoli-Calmettes Institute
Author Profile
Faézeh IZADIFAR-LEGRAND
Paoli-Calmettes Institute
Author Profile
Jean-Alain MARTIGNOLES
Hospital Saint-Antoine
Author Profile
Francois DELHOMMEAU
Hospital Saint-Antoine
Author Profile
Christine Bellanné-Chantelot
Hopital Universitaire Pitie Salpetriere
Author Profile
Jean-Francois EMILE
Ambroise Pare Hospital Group
Author Profile
Jean Donadieu
CHU Trousseau
Author Profile

Abstract

Shwachman–Diamond syndrome with Shwachman–Bodian–Diamond syndrome (SBDS) biallelic variants is a rare disorder that predisposes the carrier to malignant hemopathies but solid-cancer predisposition is poorly known. Among 155 cases entered in the French Severe Chronic Neutropenia Registry, three were identified original with malignant solid tumors (ovary, breast and esophagus). All cancers occurred in the fifth decade and, despite being at localized stages at diagnosis, they were rapidly fatal thereafter. No cancer was observed in the 14 HSCT survivors post transplantation. Based on our experience and the literature, age >40 years was the only apparent risk factor.
08 Oct 2020Submission Checks Completed
08 Oct 2020Assigned to Editor
08 Oct 2020Submitted to Pediatric Blood & Cancer
15 Oct 2020Reviewer(s) Assigned
02 Nov 2020Review(s) Completed, Editorial Evaluation Pending
04 Nov 2020Editorial Decision: Revise Major
20 Jan 2021Submission Checks Completed
20 Jan 2021Assigned to Editor
20 Jan 20211st Revision Received
18 Mar 2021Reviewer(s) Assigned
05 Apr 2021Review(s) Completed, Editorial Evaluation Pending
06 Apr 2021Editorial Decision: Accept